Drugs giant AstraZeneca's major setback as bad trial results wipe £10bn from value All Finance ASTRAZENECA investors felt the pain yesterday as a major setback for a key lung cancer treatment wiped nearly £10billion from the company’s market value. Source: Daily Express :: Finance Feed http://ift.tt/2h6UCgk Author : Unknown Share this Related Posts
EmoticonEmoticon